Pastore LLC successfully negotiated the separation of C-suite executive from a publically traded Boston based bio-tech company. Key issues involved the vesting of stock options and related plan documents, adherence to Rule 144 in the disposition of stock and the scope of non-competition agreements under Delaware law.

Tags: Firm News

More News

10

September2025

Connecticut Appellate Court Rules in Favor of Pastore LLC’s Hedge Fund Clients in Landmark Jury Trial Decision

12

August2025

Pastore LLC Obtains a $51M PJR Involving the Largest Real Estate Development in Westchester and a Greenwich Based Real Estate Developer

16

July2025

Pastore LLC Wins Unanimous Jury Verdict for Private Equity Investor
+ View More